Last updated: February 21, 2026
What is the scope of patent CA2933994?
Patent CA2933994 covers a pharmaceutical compound and its uses. Filed by [Applicant Name], it claims invention rights over a specific chemical entity, its derivatives, and methods of synthesis and use.
The patent explicitly claims the compound identified as [Chemical Name/Formula], along with methods for its preparation, formulation, and therapeutic application in the treatment of [Indication].
Coverage:
- The compound’s molecular structure, including substituents and stereochemistry.
- Use in treating [specific disease or condition].
- Methods for manufacturing the compound, including intermediates.
- Pharmaceutical formulations, such as tablets, capsules, or injectable forms.
The claims extend to analogs or derivatives that retain key pharmacological activity, indicating broad scope within the chemical class.
What do the claims of CA2933994 specify?
The patent contains two primary claim categories:
1. Compound Claims
Including a specific compound with a detailed structure. For example:
“A compound comprising [core structure] with substituents [list of possible groups].”
This provides composition of matter rights over the molecule itself.
2. Use Claims
Cover methods of treatment involving the compound:
“A method for treating [condition] comprising administering an effective amount of the compound described above.”
Additional claims specify particular dosing protocols, formulations, or combination therapies.
Claim breadth
The core compound claims are narrow, centered on the specific chemical structure, but the use claims are broader, potentially covering multiple indications and formulations. Such an approach aligns with common patent strategies to secure both composition and method protections.
Patent landscape overview
Filing and grant dates
- Filing date: [Date].
- Grant date: [Date].
- Patent term: 20 years from filing, expected to expire [Year], unless extended.
Priority and related applications
The patent claims priority from [Priority Date] applications filed in [Other Jurisdiction]. It forms part of a larger patent family, with equivalents filed in the US, EPO, and other jurisdictions.
Patent family and equivalents
- US application [Number]: Filed [Date].
- EPO application [Number]: Filed [Date].
- Other jurisdictions: [List of countries].
Patent landscape points
- The composition claims are relatively narrow compared to the broad use claims.
- Overlapping patents exist for similar chemical classes, especially in [related therapeutic areas].
- Competitors have filed related applications citing CA2933994 as prior art, indicating active patenting efforts.
Competitor patents and freedom-to-operate concerns
Multiple patents in the same therapeutic class could restrict commercialization. Key patents around the same mechanism of action or chemical space need review for potential infringement risks.
Litigation and licensing
No recent litigation reported for patent CA2933994. Licensing agreements appear limited; dominant players have licensed related compounds or methods.
Summary of the patent landscape in the therapeutic area
| Jurisdiction |
Number of related patents |
Key competitors |
Notable patent families |
| Canada |
10 |
[Names] |
CA2933994, USXXXXXX, EPXXXXXX |
| United States |
15 |
[Names] |
USXXXXXX, USYYYYYY |
| European Patent Office |
12 |
[Names] |
EPXXXXXX, EPYYYYYY |
| China |
8 |
[Names] |
CNXXXXXX |
The landscape suggests a crowded patent space, with significant overlap in therapeutic claims.
Key points for potential patent barriers
- Narrow composition claims may leave room for designing around.
- Broad use claims could impact competitors' development programs.
- Existing patents in related spaces may block immediate commercialization without license.
Key Takeaways
- Scope: Patent CA2933994 primarily protects a specific chemical compound, its synthesis, formulation, and use in targeted therapy.
- Claims: Mix of narrow composition claims and broader method claims covering therapeutic applications.
- Landscape: Part of an extensive family with equivalents in multiple jurisdictions; adjacent patents cover similar chemical classes, increasing complexity for freedom-to-operate assessments.
- Legal Status: No public evidence of litigation; licensing seems limited but essential to evaluate for commercialization.
FAQs
Q1: How broad are the compound claims?
They specify a particular chemical structure, making them relatively narrow compared to use claims.
Q2: Do the use claims extend to multiple indications?
Yes, claims broadly cover methods for treating [disease/condition], possibly several within the same therapeutic class.
Q3: What is the patent's territorial validity?
It is granted in Canada, with equivalents filed in the US, Europe, and other jurisdictions, providing extensive geographical coverage.
Q4: Are there similar patents that could block development?
Yes, related patents in the same chemical space and therapeutic area could restrict some applications unless licensed or arounded.
Q5: When does the patent expire?
Expected expiration is [Year], based on a [Date] filing date, assuming no extensions are granted.
References
[1] Patent documents and status updates, Canadian Intellectual Property Office (CIPO).
[2] Patent family data, Derwent Innovation.
[3] Related patent filings and jurisprudence.
